Literature DB >> 14693737

Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.

.   

Abstract

Mathematical methods exist to determine the fractions of sex hormones bound to albumin, bound to sex hormone binding globulin (SHBG), or unbound, using total hormone concentration and SHBG concentration. We used data from eight prospective studies of postmenopausal women to assess the validity of these estimates for fractions of estradiol (E2) and to investigate the impact of using calculated values in breast cancer relative risk (RR) models. Comparisons were made between measured and calculated concentrations of free and non-SHBG-bound E2 in four studies. Relationships between the hormone fractions were investigated and a sensitivity analysis of the calculation performed. Breast cancer RRs were estimated using conditional logistic regression by quintiles of free E2. There is a high correlation (r > 0.91) between calculated and measured values of both free and non-SHBG-bound E2. The calculation is highly sensitive to total hormone concentration but is relatively insensitive to SHBG concentration. In studies with both measured and calculated values, the RRs of breast cancer by quintile of free E2 were almost identical for both estimates; using calculated values in all possible studies the RR in the highest compared with the lowest quintile of free E2 was 2.29 (95% confidence interval, 1.65-3.19). The mathematical method used to calculate fractions of E2 is valid, and RR analyses using calculated values produce similar results to those using measured values. This suggests that for epidemiological studies, it is only necessary to measure total E2 concentration and SHBG concentration, with hormone fractions being obtained by calculation, producing savings in cost, time, and serum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14693737

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

Review 2.  Analysis of estrogens and androgens in postmenopausal serum and plasma by liquid chromatography-mass spectrometry.

Authors:  Qingqing Wang; Lisa Bottalico; Clementina Mesaros; Ian A Blair
Journal:  Steroids       Date:  2014-08-20       Impact factor: 2.668

3.  Estimating systemic exposure to levonorgestrel from an oral contraceptive.

Authors:  Cale N Basaraba; Carolyn L Westhoff; Malcolm C Pike; Renu Nandakumar; Serge Cremers
Journal:  Contraception       Date:  2016-12-30       Impact factor: 3.375

4.  Ultrasensitive quantification of serum estrogens in postmenopausal women and older men by liquid chromatography-tandem mass spectrometry.

Authors:  Qingqing Wang; Kannan Rangiah; Clementina Mesaros; Nathaniel W Snyder; Anil Vachani; Haifeng Song; Ian A Blair
Journal:  Steroids       Date:  2015-01-29       Impact factor: 2.668

5.  Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range.

Authors:  David M Rissin; David R Fournier; Tomasz Piech; Cheuk W Kan; Todd G Campbell; Linan Song; Lei Chang; Andrew J Rivnak; Purvish P Patel; Gail K Provuncher; Evan P Ferrell; Stuart C Howes; Brian A Pink; Kaitlin A Minnehan; David H Wilson; David C Duffy
Journal:  Anal Chem       Date:  2011-02-23       Impact factor: 6.986

6.  Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Teresa A Phillips; Trina Metheny; Brian K Petroff; Thomas C Havighurst; KyungMann Kim; Howard H Bailey; Brandy M Heckman-Stoddard
Journal:  Cancer Prev Res (Phila)       Date:  2015-09-21

7.  Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer.

Authors:  Carol J Fabian; Seema A Khan; Judy E Garber; William C Dooley; Lisa D Yee; Jennifer R Klemp; Jennifer L Nydegger; Kandy R Powers; Amy L Kreutzjans; Carola M Zalles; Trina Metheny; Teresa A Phillips; Jinxiang Hu; Devin C Koestler; Prabhakar Chalise; Nanda Kumar Yellapu; Cheryl Jernigan; Brian K Petroff; Stephen D Hursting; Bruce F Kimler
Journal:  Cancer Prev Res (Phila)       Date:  2020-04-20

8.  Sex hormone-binding globulin and risk of clinical diabetes in American black, Hispanic, and Asian/Pacific Islander postmenopausal women.

Authors:  Brian H Chen; Kathleen Brennan; Atsushi Goto; Yiqing Song; Najib Aziz; Nai-chieh Y You; Melissa F Wellons; JoAnn E Manson; Donna L White; Anthony W Butch; Simin Liu
Journal:  Clin Chem       Date:  2012-08-20       Impact factor: 8.327

9.  Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study.

Authors:  E L Ding; Y Song; J E Manson; N Rifai; J E Buring; S Liu
Journal:  Diabetologia       Date:  2007-08-14       Impact factor: 10.122

10.  Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.

Authors:  Valerie A McCormack; Mitch Dowsett; Elizabeth Folkerd; Nichola Johnson; Claire Palles; Ben Coupland; Jeff M Holly; Sarah J Vinnicombe; Nicholas M Perry; Isabel dos Santos Silva
Journal:  Breast Cancer Res       Date:  2009-06-22       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.